Suzuki, S.; Furuhashi, M.; Tsugeno, Y.; Umetsu, A.; Ida, Y.; Hikage, F.; Ohguro, H.; Watanabe, M.
Comparison of the Drug-Induced Efficacies between Omidenepag Isopropyl, an EP2 Agonist and PGF2α toward TGF-β2-Modulated Human Trabecular Meshwork (HTM) Cells. J. Clin. Med. 2022, 11, 1652.
https://doi.org/10.3390/jcm11061652
AMA Style
Suzuki S, Furuhashi M, Tsugeno Y, Umetsu A, Ida Y, Hikage F, Ohguro H, Watanabe M.
Comparison of the Drug-Induced Efficacies between Omidenepag Isopropyl, an EP2 Agonist and PGF2α toward TGF-β2-Modulated Human Trabecular Meshwork (HTM) Cells. Journal of Clinical Medicine. 2022; 11(6):1652.
https://doi.org/10.3390/jcm11061652
Chicago/Turabian Style
Suzuki, Soma, Masato Furuhashi, Yuri Tsugeno, Araya Umetsu, Yosuke Ida, Fumihito Hikage, Hiroshi Ohguro, and Megumi Watanabe.
2022. "Comparison of the Drug-Induced Efficacies between Omidenepag Isopropyl, an EP2 Agonist and PGF2α toward TGF-β2-Modulated Human Trabecular Meshwork (HTM) Cells" Journal of Clinical Medicine 11, no. 6: 1652.
https://doi.org/10.3390/jcm11061652
APA Style
Suzuki, S., Furuhashi, M., Tsugeno, Y., Umetsu, A., Ida, Y., Hikage, F., Ohguro, H., & Watanabe, M.
(2022). Comparison of the Drug-Induced Efficacies between Omidenepag Isopropyl, an EP2 Agonist and PGF2α toward TGF-β2-Modulated Human Trabecular Meshwork (HTM) Cells. Journal of Clinical Medicine, 11(6), 1652.
https://doi.org/10.3390/jcm11061652
